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Abstract
Purpose: Recently, a complement component 1 inhibitor (SERPING1) gene polymorphism was identified as a novel risk
factor for age-related macular degeneration (AMD) in Caucasians. We aimed to investigate whether variations in SERPING1
are associated with typical AMD or with polypoidal choroidal vasculopathy (PCV) in a Japanese population.
Methods: We performed a case-control study in a group of Japanese patients with typical AMD (n=401) or PCV (n=510)
and in 2 independent control groups—336 cataract patients without age-related maculopathy and 1,194 healthy Japanese
individuals. Differences in the observed genotypic distribution between the case and control groups were tested using chi-
square test for trend. Age and gender were adjusted using logistic regression analysis.
Results: We targeted rs2511989 as the haplotype-tagging single nucleotide polymorphism (SNP) for the SERPING1 gene,
which was reported to be associated with the risk of AMD in Caucasians. Although we compared the genotypic distributions
of rs2511989 in typical AMD and PCV patients against 2 independent control groups (cataract patients and healthy
Japanese individuals), SERPING1 rs2511989 was not significantly associated with typical AMD (P=0.932 and 0.513,
respectively) or PCV (P=0.505 and 0.141, respectively). After correction for age and gender differences based on a logistic
regression model, the difference in genotypic distributions remained insignificant (P.0.05). Our sample size had a statistical
power of more than 90% to detect an association of a risk allele with an odds ratio reported in the original studies for
rs2511989 for developing AMD.
Conclusions: In the present study, we could not replicate the reported association between SERPING1 and either
neovascular AMD or PCV in a Japanese population; thus, the results suggest that SERPING1 does not play a significant role in
the risk of developing AMD or PCV in Japanese.
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Introduction
Age-related macular degeneration (AMD) is the leading cause of
visual loss in the developed world [1]. Several genes have been
reported to be associated with this disease, including complement
factor H [2–4] and the age-related maculopathy susceptibility 2/
HtrA serine peptidase 1 (ARMS2/HTRA1) region [5,6], and
subsequent studies have replicated the association between
susceptibility genes and the development of AMD using a different
ethnic cohort [7–10].
Inner choroidal vascular networks that terminate in polypoidal
lesions are defined as polypoidal choroidal vasculopathy (PCV),
and are typically visualized by indocyanine green angiography
[11]. Whether PCV represents a subtype of neovascular AMD
remains controversial; moreover, whether this condition represents
inner choroidal vascular abnormalities or is a variety of choroidal
neovascularization remains unknown [12]. Previous studies
identified several genes that contribute to the development of
PCV; however, almost all reported genetic risk factors for PCV are
the same as for AMD [13–15], and this suggests that AMD and
PCV share, at least in part, the same genetic background.
Studiesincohortsfromboth theUnitedKingdomand the United
States have shown that the complement component 1 inhibitor
(SERPING1) gene is positively associated with AMD [16]. However,
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19108another study ina largercohort (n=7723 and 2327) which involved
the same population could not replicate the finding of the previous
study [17,18]. Recently, Lee et al. have shown that SERPING1 is
positivelyassociatedwithAMDinCaucasians[19],butwhetherthis
gene is truly associated with AMD remains controversial.
Furthermore, the association of SERPING1 with AMD has been
evaluated also in Asians. Lu et al. examined the association in 194
AMD patients and 285 controls and reported that SERPING1 is
not associated with AMD in the Chinese population [20]. The
association between PCV and SERPING1 has also been evaluated
in a smaller Chinese cohort (118 patients and 115 controls), also
with negative findings [21]. So far, all Asian studies for SERPING1
did use smaller cohorts than those of original studies and not
consider their statistical power. For evaluating the true gene-
disease association, it would be helpful to replicate the positive
association reported in previous studies using a different ethnic
cohort. The aim of this study, which involved a relatively large
number of participants, was to investigate whether the SERPING1
gene variants are associated with typical AMD or PCV in a
Japanese population.
Materials and Methods
All procedures in this study adhered to the tenets of the
Declaration of Helsinki. This study was approved by the Ethics
Committee of each institute involved (Kyoto University Graduate
School and Faculty of Medicine, Ethics Committee, the Ethical
Table 1. Characteristics of the Study Population.
Cases Controls
tAMD PCV Control 1* Control 2
{
No. of participants 401 510 336 1194
Age Mean 6 SD 77.3868.39 74.9867.77 74.1668.42 50.34615.9
Gender Men 287 372 142 493
Women 114 138 194 701
tAMD, typical age-related macular degeneration; PCV, polypoidal choroidal
vasculopathy; SD, standard deviation.
*Cataract patients without age-related maculopathy.
{Healthy Japanese individuals.
doi:10.1371/journal.pone.0019108.t001
Figure 1. Linkage disequilibrium (LD) structure across the complement component 1 inhibitor (SERPING1) gene in Caucasian and
Japanese populations. Genotype data were retrieved from HapMap CEU (Utah residents with ancestry from northern and western Europe; A) and
JPT (Japanese in Tokyo, Japan; B) data sets. Haplotype blocks were determined using the ‘‘four-gamete rule’’ option in Haploview; all HapMap single
nucleotide polymorphisms on SERPING1 gene are in the same block in both populations. Each box provides estimated statistics of the coefficient of
determination (r
2), with darker shades representing stronger LD.
doi:10.1371/journal.pone.0019108.g001
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Committee of Kobe City Medical Center General Hospital, the
Ethical Committee of Ozaki Eye Hospital, the Ethical Committee
of the Otsu Red Cross Hospital, the Ethical Committee of
Nagahama City Hospital, and the Ethical Committee at Aichi
Cancer Center). All of the patients were fully informed about the
purpose and procedures of this study, and written consent was
obtained from each.
In this study, 401 patients with typical AMD and 510 patients
with PCV were recruited from the Department of Ophthalmology
at Kyoto University Hospital, Fukushima Medical University
Hospital, and Kobe City Medical Center General Hospital. The
control group included 2 populations: (1) 336 individuals who
underwent cataract surgery and had no age-related maculopathy
(ARM) (Control 1) were recruited from the Department of
Ophthalmology, Kyoto University Hospital, Ozaki Eye Hospital,
Japanese Red Cross Otsu Hospital, and Nagahama City Hospital;
and (2) 1194 healthy individuals who were recruited from the
Aichi Cancer Center Research Institute as the general population
control (Control 2). AMD and ARM were defined according to
the International Classification System for ARM and AMD [22].
The diagnosis of PCV was based on indocyanine green
angiography, which showed a branching vascular network that
terminated in polypoidal swelling. Typical AMD were late AMD
which showed classic choroidal neovascularization (CNV), occult
CNV, or both. All diagnoses were made by 3 retina specialists
(K.Y., A.T., and A.O.); a fourth specialist (N.Y.) was consulted
when the subtype classification could not be decided on by the
initial 3 reviewers. All of the subjects were unrelated and were of
the Japanese descent.
Genomic DNAs were isolated from the peripheral blood of the
subjects by using a DNA extraction kit (QuickGene-610L,
Fujifilm, Minato, Tokyo, Japan). The samples of all the patients
with typical AMD and PCV and of cataract patients were
genotyped using a Taqman single nucleotide polymorphism (SNP)
assay with the ABI PRISM 7700 system (Applied Biosystems,
Foster City, CA). The individuals recruited from the Aichi Cancer
Center Research Institute were genotyped using Illumina Human-
Hap 610 chips (Illumina Inc., San Diego, CA).
Linkage disequilibrium (LD) structures across the SERPING1
gene were compared between the Caucasian and Japanese
populations, using genotype data retrieved from the HapMap
CEU and JPT data sets [23]. The retrieved data were loaded into
Haploview to estimate LD parameters and to identify haplotype
blocks [24]. Deviations in genotype distributions from the Hardy–
Weinberg equilibrium (HWE) were assessed using the HWE exact
test. Statistical analyses for differences in the observed genotypic
distribution were performed by the chi square test for trend;
logistic regression analysis was performed for age and gender
adjustments. The statistical power calculation was performed using
QUANTO version 1.2 [25]. P values less than 0.05 were
considered statistically significant.
Results
The demographic details of the study population are presented
in Table 1. Because all SNPs of the SERPING1 gene are in the
same haplotype block, rs2511989 was selected as the haplotype-
tagging SNP; rs2511989 was reported to be associated with the
risk of AMD in previous studies [16,19] (Fig. 1). Details of allele
and genotype counts and summary statistics for rs2511989 are
shown in Table 2. The success rate of genotyping of rs2511989
was 98.1%, and the distributions of the genotypes for all study
groups were in the Hardy–Weinberg equilibrium (P.0.05).
Although we compared the genotype distributions of rs2511989
in typical AMD and PCV patients against 2 independent control
groups (cataract patients without ARM and healthy Japanese
individuals), SERPING1 rs2511989 was not significantly associated
with typical AMD (P=0.932 and 0.513, respectively); further-
more, it was not significantly associated with PCV (P=0.505 and
0.141, respectively). After correction for age and gender
differences based on a logistic regression model, the difference in
the genotype distributions remained insignificant (P.0.05). Table 3
shows the odds ratios adjusted for age and gender under various
genetic models. We could not find a significant association in any
genetic model.
Next, we calculated our statistical power to detect an association
of a risk allele with the odds ratio reported in the previous study
that investigated the association of rs2511989 with developing
AMD. When we targeted the original study reported by Ennis
(odds ratio 0.63) [16], our sample size had more than 90% power
to detect the association (Table 2). In addition, the statistical power
calculation revealed that our sample size could detect the gene-
disease association for an odds ratio of 0.797 by more than 80%.
Discussion
In the present study, we investigated whether SERPING1 gene
variants are associated with typical AMD or with PCV in a
Japanese population. We selected rs2511989 as the haplotype-
tagging SNP, because this has been reported to be positively
associated with the risk of AMD in Caucasians. The results of this
study showed that SERPING1 rs2511989 was not associated with
the risk for typical AMD in a Japanese population; thus, the results
did not support the hypothesis that an association between the
SERPING1 gene and AMD exists. Our sample size had more than
90% power to detect the association determined in the previous
Table 2. SERPING1 rs2511989 Genotypic Distributions and Results of Association Tests and Power Analysis.
vs Control 1 vs Control 2
GG GA AA MAF P Value Adjusted P* Power
{ P Value Adjusted P* Power
{
Cases tAMD 293 102 6 0.142 0.932 0.687 93.6% 0.513 0.860 99.3%
PCV 380 125 5 0.132 0.505 0.855 95.7% 0.141 0.678 99.2%
Controls Control 1 248 76 10 0.144 - - - - - -
Control 2 859 308 27 0.152 - - - - - -
tAMD, typical age-related macular degeneration; PCV, polypoidal choroidal vasculopathy; MAF, minor allele frequency.
*Adjusted for age and gender.
{Statistical power for detecting the association reported in the previous study (odds ratio 0.63).
doi:10.1371/journal.pone.0019108.t002
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we found no evidence to support the role played by SERPING1
rs2511989 in the susceptibility to PCV, and this finding is in
agreement with that of the previous study in a Chinese population
[21].
The reported association between AMD and SERPING1
rs2511989 is shown in Table 4. The size of our Japanese cohort
was similar to that of the original study [16]. Furthermore, the
statistical power calculation revealed that our sample size could
detect the gene-disease association for an odds ratio of 0.797 by
more than 80%. Had there been a true protective effect of
SERPING1 gene variants for developing AMD at the same level as
was reported in previous studies [16,19], the statistical power of our
study would have detected such an association. Differences in the
ethnicities of subjects might be 1 reason for the difference observed
between the results of this study in a Japanese cohort and those of
the previous study in a Caucasian cohort. Frequency of the minor
allele of rs2511989 was reportedly greater in the earlier study in a
Caucasian population than that of the present study in a Japanese
population.Infact,inreference totheallelefrequencydatafromthe
HapMap, all genetic variants across the SERPING1 gene showed
smaller minor allele frequency in Japanese than in Caucasians.
Another possible explanation for the differences between our
findings and those of other studies in different ethnic cohorts may
include a difference in the phenotypes of AMD. Numerous studies
have reported that distinguishing features of Asian AMD include
male predominance, unilateral presentation, comparatively low
incidence of soft drusen, and greater prevalence of neovascular
AMD and PCV [26–29]. To address these concerns, we classified
AMD patients into those with typical AMD and those with PCV,
but the possible hidden differences in the phenotypes cannot be
excluded. Alternatively, considering the fact that genetic variants
that are associated with a particular disease in 1 population may
not necessarily be associated in another population [30–32];
moreover, it is possible that gene-disease association of SERPING1
in populations from East Asia is very weak or absent as compared
with Caucasian populations.
In this study, we used general population-based controls
(Control 2). The possibility exists that some of the eyes in the
control 2 group might have or develop AMD or PCV, and this
might be a possible explanation for the negative results in this
study. However, because the prevalence of AMD in the general
population is estimated to be 0.5% in the Japanese population
[33], the loss of the statistical power of association analysis must be
negligible. In addition, we also performed a subset analysis on
Table 3. Odds Ratios in Various Genetic Models.
Adjusted Odds Ratio (95% Confidence
Interval)*
Group Model vs tAMD vs PCV
Control 1 Additive 0.938 (0.687–1.281) 0.972 (0.72–1.312)
Dominant 1.283 (0.746–2.204) 0.598 (0.338–1.056)
Recessive 0.934 (0.783–1.114) 1.283 (0.746–2.204)
Control 2 Additive 1.034 (0.716–1.491) 0.933 (0.673–1.294)
Dominant 0.940 (0.470–1.879) 0.709 (0.349–1.440)
Recessive 1.025 (0.839–1.254) 0.983 (0.823–1.174)
*Adjusted for age and gender.
tAMD, typical age-related macular degeneration; PCV, polypoidal choroidal
vasculopathy.
doi:10.1371/journal.pone.0019108.t003
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that some of the eyes in the control group might develop AMD or
PCV. However, no new significant differences in the genotypic
distributions were found in the current study (data not shown).
Thus, we concluded that the result of the analysis using control 2 is
valuable as reference data which supports a lack of association
between SERPING1 and both typical AMD and PCV in a
Japanese population. Another limitation is about geographical
difference of Control 1, which may influence genetic background
of the participants. However, because the Japanese population has
been reported to have a rather small genetic diversity, according to
data from the SNP discovery project in Japan [34], geographical
difference should not be affect our statistical results.
In conclusion, this study showed a lack of association between
SERPING1 and both typical AMD and PCV in a Japanese
population; thus, the results suggest that SERPING1 does not play
a significant role in the risk of developing AMD or PCV in
Japanese.
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